Published in Blood Weekly, December 13th, 2001
These two animal studies from The Montreal Heart Institute and The University of Oklahoma Health Sciences Center, used Freezor technology from CryoCath Technologies, the world leader in cryotherapy products to treat cardiovascular disease, to generate their findings. The papers were presented at the American Heart Association conference in Anaheim, California, November 13, 2001.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.